Hematologic and cytogenetic response during the 1-year study period
. | Hematologic response . | . | . | Cytogenetic response . | . | . | . | . | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | . | Complete . | . | . | Complete . | . | Major . | . | ||||||
Time . | NE, no. . | No. . | % . | NE, no. . | No. . | % . | No. . | % . | ||||||
3 mo | 0 | 170 | 89 | 36 | 30 | 16 | 79 | 41 | ||||||
6 mo | 0 | 171 | 89 | 33 | 51 | 27 | 85 | 44 | ||||||
9 mo | 5 | 164 | 86 | 38 | 55 | 29 | 80 | 42 | ||||||
12 mo | 6 | 153 | 80 | 27 | 64 | 33 | 91 | 48 | ||||||
Overall | 0 | 171 | 89 | 2 | 85 | 44 | 118 | 61 |
. | Hematologic response . | . | . | Cytogenetic response . | . | . | . | . | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | . | Complete . | . | . | Complete . | . | Major . | . | ||||||
Time . | NE, no. . | No. . | % . | NE, no. . | No. . | % . | No. . | % . | ||||||
3 mo | 0 | 170 | 89 | 36 | 30 | 16 | 79 | 41 | ||||||
6 mo | 0 | 171 | 89 | 33 | 51 | 27 | 85 | 44 | ||||||
9 mo | 5 | 164 | 86 | 38 | 55 | 29 | 80 | 42 | ||||||
12 mo | 6 | 153 | 80 | 27 | 64 | 33 | 91 | 48 | ||||||
Overall | 0 | 171 | 89 | 2 | 85 | 44 | 118 | 61 |
The calculations are always based on all 191 cases (intention-to-treat). All cases but 2 were evaluable for the response at least once (overall), whereas several cases were nonevaluable (NE) for cytogenetic response at each time point.